Dorien Brouwer

120 Chapter 2.2 PART 2 Table 4: Change in secondary outcomes after six months follow-up Control Intervention p aBeta (95% CI) Waist circumference, mean (SD) (n=75) 2.42 (5.7) 1.41 (8.2) 0.53 -0.84 (-4.51-2.83) Weight loss, mean (SD) (n=42) -4.8 (2.5) -4.18 (5.2) 0.67 -1.23 (-4.93-2.47) Systolic blood pressure, mean (SD) (n= 92) -8.8 (18) -6.2 (17) 0.45 -2.07 (-7.66-3.53) Diastolic blood pressure, mean (SD) (n=92) -5.0 (11) -3.5 (11) 0.51 -1.71 (-5.27-1.85) Total cholesterol, mean (SD) (n= 89) -0.80 (1.2) -0.58 (1.2) 0.39 0.41 (0.03-0.80) Glucose, mean (SD) (n=79) -0.05 (3.0) 0.49 (1.6) 0.32 0.70 (-0.03-1.43) Intention to change physical activity, median (IQ) (n= 88) 0.0 (0-1) 0 (0-1) 0.82 -0.19 (-0.84-0.44) Intention to followhealthy diet , median (IQ) (n= 82) 0 (-1-1) 0 (0-1) 0.58 0.17 (-0.76-1.19) Intention to quit smoking, median (IQ) (n= 6) -1 (-1-0) 0 (-2-0) 1.00 0.43 (-1.91-2.79) Self-efficacy overall, median (IQ) (n= 95) 3.7 (3-4) 3.7 (3-4) 0.09 0.19 (-0.07-0.46) Self-efficacy smokers, median (IQ) (n= 14) 19 (17-23) 25.5 (19-28) 0.06 1.01 (-13.2-15.2) Self-efficacy non smokers, median (IQ)( n= 81) 22 (19-24) 22 (21-23) 0.64 -0.58 (-2.33-1.15) 1 adjusted for age ,sex, history of TIA, baseline self-efficacy and smoking status at baseline